These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 16223949)

  • 1. Current and developing technologies for monitoring agents of bioterrorism and biowarfare.
    Lim DV; Simpson JM; Kearns EA; Kramer MF
    Clin Microbiol Rev; 2005 Oct; 18(4):583-607. PubMed ID: 16223949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid diagnostic assays in the genomic biology era: detection and identification of infectious disease and biological weapon agents.
    Peruski LF; Peruski AH
    Biotechniques; 2003 Oct; 35(4):840-6. PubMed ID: 14579750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleic acid approaches for detection and identification of biological warfare and infectious disease agents.
    Ivnitski D; O'Neil DJ; Gattuso A; Schlicht R; Calidonna M; Fisher R
    Biotechniques; 2003 Oct; 35(4):862-9. PubMed ID: 14579752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoassay of infectious agents.
    Andreotti PE; Ludwig GV; Peruski AH; Tuite JJ; Morse SS; Peruski LF
    Biotechniques; 2003 Oct; 35(4):850-9. PubMed ID: 14579751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heightened sense for sensing: recent advances in pathogen immunoassay sensing platforms.
    Fischer NO; Tarasow TM; Tok JB
    Analyst; 2007 Mar; 132(3):187-91. PubMed ID: 17325749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Sequencing for Biodefense: Biothreat Detection, Forensics, and the Clinic.
    Minogue TD; Koehler JW; Stefan CP; Conrad TA
    Clin Chem; 2019 Mar; 65(3):383-392. PubMed ID: 30352865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex diagnostic platforms for detection of biothreat agents.
    Cirino NM; Musser KA; Egan C
    Expert Rev Mol Diagn; 2004 Nov; 4(6):841-57. PubMed ID: 15525226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioterrorism: agents of concern.
    Cieslak TJ; Eitzen EM
    J Public Health Manag Pract; 2000 Jul; 6(4):19-29. PubMed ID: 10977609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of molecular recognition technologies for detection of biological threat agents.
    Iqbal SS; Mayo MW; Bruno JG; Bronk BV; Batt CA; Chambers JP
    Biosens Bioelectron; 2000; 15(11-12):549-78. PubMed ID: 11213217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing and validation of high density resequencing microarray for broad range biothreat agents detection.
    Leski TA; Lin B; Malanoski AP; Wang Z; Long NC; Meador CE; Barrows B; Ibrahim S; Hardick JP; Aitichou M; Schnur JM; Tibbetts C; Stenger DA
    PLoS One; 2009 Aug; 4(8):e6569. PubMed ID: 19668365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid polymerase chain reaction-based screening assay for bacterial biothreat agents.
    Yang S; Rothman RE; Hardick J; Kuroki M; Hardick A; Doshi V; Ramachandran P; Gaydos CA
    Acad Emerg Med; 2008 Apr; 15(4):388-92. PubMed ID: 18370996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acid-based diagnostics for infectious diseases in public health affairs.
    Yu AC; Vatcher G; Yue X; Dong Y; Li MH; Tam PH; Tsang PY; Wong AK; Hui MH; Yang B; Tang H; Lau LT
    Front Med; 2012 Jun; 6(2):173-86. PubMed ID: 22660977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognizing biothreat diseases: realistic training using standardized patients and patient simulators.
    Atlas RM; Clover RD; Carrico R; Wesley G; Thompson M; McKinney WP
    J Public Health Manag Pract; 2005 Nov; Suppl():S143-6. PubMed ID: 16205536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCR/LDR/universal array platforms for the diagnosis of infectious disease.
    Pingle M; Rundell M; Das S; Golightly LM; Barany F
    Methods Mol Biol; 2010; 632():141-57. PubMed ID: 20217576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confronting the threat of bioterrorism: realities, challenges, and defensive strategies.
    Green MS; LeDuc J; Cohen D; Franz DR
    Lancet Infect Dis; 2019 Jan; 19(1):e2-e13. PubMed ID: 30340981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioterrorism: Preparing for the impossible or the improbable.
    Karwa M; Currie B; Kvetan V
    Crit Care Med; 2005 Jan; 33(1 Suppl):S75-95. PubMed ID: 15640684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current methods for the rapid diagnosis of bioterrorism-related infectious agents.
    Fan J; Kraft AJ; Henrickson KJ
    Pediatr Clin North Am; 2006 Oct; 53(5):817-42, vii-viii. PubMed ID: 17027612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in detecting and responding to threats from bioterrorism and emerging infectious disease.
    Rotz LD; Hughes JM
    Nat Med; 2004 Dec; 10(12 Suppl):S130-6. PubMed ID: 15577931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biothreat agents and pathology laboratories.
    Nelson A; Wilson ML
    Semin Diagn Pathol; 2007 Nov; 24(4):209-16. PubMed ID: 18085061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological security confronting bioterrorism].
    Suárez Fernández G
    An R Acad Nac Med (Madr); 2002; 119(1):77-89; discussion 89-95. PubMed ID: 12197209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.